MSB 7.69% $1.19 mesoblast limited

Ann: Mesoblast Partners with BMT CTN on Adult SR-aGVHD Trial, page-120

  1. 12,393 Posts.
    lightbulb Created with Sketch. 3370
    @Southoz - thanks for the info.

    You are another poster where we don't agree on MSB prospects, as you seem to have an axe to grind with Mesoblast for some reason, but you don't post often and back up your post with details - I certainly respect that.

    Hopefully in regards to the GVHD Adult trial, with the upcoming AGM, we will get more clarity on funding, trial design and timing.
    Let's revisit where we are with this trial once we've got more details.

    In the meantime, my point still stand - BMT CTN are experts in their field.
    Would you let your company and would the individual doctors want to be involved with a trial that is not well controlled & has minimal chance of being a success? No way!
    Sure, nothing is guaranteed - but, you do whatever you can to ensure that you set the trial up for success and in turn help to get the product to be FDA approved.

    So, in term of the GVHD Adult trial, Mesoblast' credibility has improved with the support and involvements of these BMT GVHD experts.
    It's both an endorsement of the Ryoncil product and the company

    https://hotcopper.com.au/data/attachments/5759/5759262-6d509a5ade25a072e5cea7e958387b08.jpg

    Last edited by ddwn: 23/11/23
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.19
Change
0.085(7.69%)
Mkt cap ! $1.358B
Open High Low Value Volume
$1.10 $1.20 $1.09 $13.21M 11.37M

Buyers (Bids)

No. Vol. Price($)
1 15000 $1.19
 

Sellers (Offers)

Price($) Vol. No.
$1.19 75212 5
View Market Depth
Last trade - 16.10pm 12/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.